The UK National Screening Committee (UK NSC) is aware of research into the use of three-dimensional (3D) mammography and the growing interest to use artificial intelligence (AI) in the National Health Service breast screening programme. Guidance has been published on GOV.UK on the use of Tomosynthesis 3D imaging in a clinical trial setting as part of the NHS breast screening programme.<\/p>
<\/p>
The UK NSC had also worked with Health Technology Assessments to design an evaluation of existing AI in a prospective study to look at whether it could be used to read breast screening mammograms.<\/p>
<\/p>
There are currently no plans to adopt these technologies, but evidence to inform a UK NSC decision on the use of 3D mammography and AI in the NHS breast screening programme will be reviewed by the Committee when available.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4044", "label" : {"_value" : "Biography information for Andrew Stephenson"} } , "answeringMemberConstituency" : {"_value" : "Pendle"} , "answeringMemberPrinted" : {"_value" : "Andrew Stephenson"} , "dateOfAnswer" : {"_value" : "2024-03-20", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-03-20T17:19:59.34Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-03-13", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Breast Cancer: Screening"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what her Department's planned timetable is for its evaluation of the merits of using (a) 3D mammography and (b) other new cancer screening technologies.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4412", "label" : {"_value" : "Biography information for Dr Lisa Cameron"} } , "tablingMemberConstituency" : {"_value" : "East Kilbride, Strathaven and Lesmahagow"} , "tablingMemberPrinted" : [{"_value" : "Dr Lisa Cameron"} ], "uin" : "18491"} , {"_about" : "http://data.parliament.uk/resources/1695647", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1695647/answer", "answerText" : {"_value" : "
The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing evidence-based guidance on whether new licensed medicines should be routinely funded by the National Health Service, based on an assessment of their costs and benefits.<\/p>
The NICE published guidance in 2021 and 2023 recommending Enhertu (trastuzumab deruxtecan) for the treatment of NHS patients with HER2-positive breast cancer through the Cancer Drugs Fund, and it is now available to eligible NHS patients in line with the NICE\u2019s recommendations.<\/p>
The NICE is currently evaluating Enhertu for the treatment of metastatic HER2-low breast cancer, and published final draft guidance on 5 March 2024 that does not recommend it as a clinically and cost-effective use of NHS resources. Stakeholders have until 19 March 2024 to lodge an appeal against the NICE\u2019s recommendations. The NICE currently expects to publish final guidance on 3 April 2024.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4044", "label" : {"_value" : "Biography information for Andrew Stephenson"} } , "answeringMemberConstituency" : {"_value" : "Pendle"} , "answeringMemberPrinted" : {"_value" : "Andrew Stephenson"} , "dateOfAnswer" : {"_value" : "2024-03-18", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-03-18T15:32:05.91Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-03-13", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Trastuzumab Deruxtecan"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, if her Department will take steps to encourage the England-wide roll-out of the drug Enhertu to aid the treatment of people with breast cancer.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1447", "label" : {"_value" : "Biography information for Andrew Rosindell"} } , "tablingMemberConstituency" : {"_value" : "Romford"} , "tablingMemberPrinted" : [{"_value" : "Andrew Rosindell"} ], "uin" : "18402"} , {"_about" : "http://data.parliament.uk/resources/1695648", "AnsweringBody" : [{"_value" : "Ministry of Defence"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1695648/answer", "answerText" : {"_value" : "
The Challenger 3 Main Battle Tank\u2019s core weight will be approximately 66 tonnes, although I am withholding the anticipated all-up weight of the deployable configuration as its disclosure would, or would be likely to, prejudice the capability, effectiveness or security of the Armed Forces.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4519", "label" : {"_value" : "Biography information for James Cartlidge"} } , "answeringMemberConstituency" : {"_value" : "South Suffolk"} , "answeringMemberPrinted" : {"_value" : "James Cartlidge"} , "dateOfAnswer" : {"_value" : "2024-03-21", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-03-21T16:25:58.36Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "11"} , "answeringDeptShortName" : {"_value" : "Defence"} , "answeringDeptSortName" : {"_value" : "Defence"} , "date" : {"_value" : "2024-03-13", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Challenger Tanks"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Defence, how much his Department expects the Challenger 3 Main Battle Tank to weigh in tonnes.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/400", "label" : {"_value" : "Biography information for John Healey"} } , "tablingMemberConstituency" : {"_value" : "Wentworth and Dearne"} , "tablingMemberPrinted" : [{"_value" : "John Healey"} ], "uin" : "18356"} , {"_about" : "http://data.parliament.uk/resources/1695649", "AnsweringBody" : [{"_value" : "Foreign, Commonwealth and Development Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1695649/answer", "answerText" : {"_value" : "
Extradition is a matter for the Home Office, the Crown Prosecution Service, and the courts. The Foreign, Commonwealth and Development Office has not had recent discussions with the US on the UK-US Extradition Treaty.<\/p>
With regards to Anne Sacoolas, she has now been sentenced. We engaged frequently with the US on this case when it was ongoing: in 2022, it was raised at least seven times by FCDO ministers or senior officials with US counterparts.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4033", "label" : {"_value" : "Biography information for David Rutley"} } , "answeringMemberConstituency" : {"_value" : "Macclesfield"} , "answeringMemberPrinted" : {"_value" : "David Rutley"} , "dateOfAnswer" : {"_value" : "2024-03-18", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-03-18T19:06:18.32Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "208"} , "answeringDeptShortName" : {"_value" : "Foreign, Commonwealth and Development Office"} , "answeringDeptSortName" : {"_value" : "Foreign, Commonwealth and Development Office"} , "date" : {"_value" : "2024-03-13", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "USA: Extradition"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Minister of State, Foreign, Commonwealth and Development Office, what recent discussions (a) Ministers and (b) officials in his Department have had with their US counterparts on the UK-US Extradition Treaty, in the context (i) the case of Anne Sacoolas and (ii) other prominent cases.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/373", "label" : {"_value" : "Biography information for Sir David Davis"} } , "tablingMemberConstituency" : {"_value" : "Haltemprice and Howden"} , "tablingMemberPrinted" : [{"_value" : "Sir David Davis"} ], "uin" : "18355"} , {"_about" : "http://data.parliament.uk/resources/1695650", "AnsweringBody" : [{"_value" : "Department for Levelling Up, Housing and Communities"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1695650/answer", "answerText" : {"_value" : "
We have committed to strengthening national planning policy so that it better supports the needs of Research and Development, and will consult on these changes in due course.<\/p>
We are also working to make investment in this sector more attractive. This includes working with local planning authorities to encourage the use of proactive planning tools, such as Local Development Orders, to make it easier to bring forward development.<\/p>
To support this, the Autumn Statement announced £5 million of funding to help local planning authorities prepare Local Development Orders for commercial development.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4652", "label" : {"_value" : "Biography information for Lee Rowley"} } , "answeringMemberConstituency" : {"_value" : "North East Derbyshire"} , "answeringMemberPrinted" : {"_value" : "Lee Rowley"} , "dateOfAnswer" : {"_value" : "2024-03-18", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-03-18T13:32:31.993Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "211"} , "answeringDeptShortName" : {"_value" : "Levelling Up, Housing and Communities"} , "answeringDeptSortName" : {"_value" : "Levelling Up, Housing and Communities"} , "date" : {"_value" : "2024-03-13", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Laboratories: Planning Permission"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Levelling Up, Housing and Communities, what steps his Department is taking through the planning system to increase the availability of laboratory space.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4124", "label" : {"_value" : "Biography information for Chi Onwurah"} } , "tablingMemberConstituency" : {"_value" : "Newcastle upon Tyne Central"} , "tablingMemberPrinted" : [{"_value" : "Chi Onwurah"} ], "uin" : "18436"} , {"_about" : "http://data.parliament.uk/resources/1695651", "AnsweringBody" : [{"_value" : "Department for Levelling Up, Housing and Communities"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1695651/answer", "answerText" : {"_value" : "
FY<\/strong><\/p><\/td> LCV total spend(£million)<\/strong><\/p><\/td><\/tr> 2019-20<\/p><\/td> £94.3<\/p><\/td><\/tr> 2020-21<\/p><\/td> £208.5<\/p><\/td><\/tr> 2021-22<\/p><\/td> £209.3<\/p><\/td><\/tr> 2022-23<\/p><\/td> £189.2<\/p><\/td><\/tr><\/tbody><\/table> <\/p> <\/p> <\/p> The LCV total spend on operating costs by financial year is as follows:<\/p> <\/p> <\/p> FY<\/strong><\/p><\/td> LCV total spend (£million)<\/strong><\/p><\/td><\/tr> 2019-20<\/p><\/td> £12.5<\/p><\/td><\/tr> 2020-21<\/p><\/td> £14<\/p><\/td><\/tr> 2021-22<\/p><\/td> £12.5<\/p><\/td><\/tr> 2022-23<\/p><\/td> £13.2<\/p><\/td><\/tr><\/tbody><\/table> <\/p> <\/p> LCV is a specific project team in DE&S and the figures above represent the total spend of that team. The figures do not represent the total spend on all land combat vehicles across the Department which would not be held centrally and would not be answerable without a disproportionate cost.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4519", "label" : {"_value" : "Biography information for James Cartlidge"}
}
, "answeringMemberConstituency" : {"_value" : "South Suffolk"}
, "answeringMemberPrinted" : {"_value" : "James Cartlidge"}
, "dateOfAnswer" : {"_value" : "2024-04-03", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-04-03T14:52:53.46Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "11"}
, "answeringDeptShortName" : {"_value" : "Defence"}
, "answeringDeptSortName" : {"_value" : "Defence"}
, "date" : {"_value" : "2024-03-13", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Armoured Fighting Vehicles: Procurement"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Defence, how much his Department has spent on land combat vehicles in each financial year since 2019-20.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/483", "label" : {"_value" : "Biography information for Maria Eagle"}
}
, "tablingMemberConstituency" : {"_value" : "Garston and Halewood"}
, "tablingMemberPrinted" : [{"_value" : "Maria Eagle"}
], "uin" : "18379"}
], "itemsPerPage" : 10, "next" : "https://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.dateOfAnswer=2018-11-19&_page=1&min-questionFirstAnswered.=2024-03-07T09%3A01%3A09.02Z&max-dateTabled=2024-03-13", "page" : 0, "startIndex" : 1, "totalResults" : 2996, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}
|